Impact of a Letter Encouraging Pneumococcal Vaccination on the 1-year Vaccination Rate in Heart Failure Patients With a Primary Care Physician
1 other identifier
interventional
12,000
1 country
1
Brief Summary
Heart failure affects more than 1.5 million people in France, resulting in over 70,000 deaths and more than 165,000 hospitalizations each year. Viral and bacterial infections are frequently associated with episodes of acute heart failure in patients with chronic heart failure (CHF). Lower respiratory tract infections, such as influenza and pneumococcus, are common causes of hospitalization for decompensated heart failure, leading to increased morbidity and mortality. Studies have shown that pneumococcal vaccination can reduce the risks of heart attack or stroke in patients with heart failure. However, despite vaccination recommendations, coverage rates remain low, especially for pneumococcus. In this study, we will evaluate the impact of an incentive letter for pneumococcal vaccination on one-year hospitalization rate in patients with heart failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedFirst Submitted
Initial submission to the registry
April 8, 2024
CompletedFirst Posted
Study publicly available on registry
April 11, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedApril 11, 2024
April 1, 2024
1.2 years
April 8, 2024
April 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
1-year Pneumococcus vaccination rate
at 1-year
Secondary Outcomes (3)
1-year all-cause hospital admission rate
at 1-year
1-year specific hospital admission rate
at 1-year
1-year all-cause mortality rate
at 1-year
Study Arms (2)
Incentive letter for pneumococcal vaccination to the patient and to the GP
EXPERIMENTALNo letter sent
NO INTERVENTIONInterventions
Incentive letter for pneumococcal vaccination to the patient and to the GP
Eligibility Criteria
You may qualify if:
- Adult patients over 45
- Residing in the Occitanie region, France
- With heart failure registered as ALD
- Who have declared an attending physician
- Who have not received a pneumococcal vaccination for more than 24 months (due to the length of time available in the database)
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Montpellier University Hospital
Montpellier, 34090, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 8, 2024
First Posted
April 11, 2024
Study Start
January 2, 2023
Primary Completion
April 1, 2024
Study Completion
June 1, 2024
Last Updated
April 11, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share